Glympse Bio

Glympse Bio

Glympse Bio

Transforming disease monitoring for patients, providers, and society. Imagine a future where a simple urine test can detect deadly diseases before they get out of control. A future when diseases can be intercepted and people dont become patients.
Founded
2015
Raised
$68.7M
Follow us
Alexa global traffic share
Twitter followers
15 Jul 2020
$46,700,000
Venture capital (Series B)

Glympse Bio raises more than $46M in Series B round for biosensor technology

MedCity News
+1
09 Oct 2018
$22,000,000
Venture capital (Series A)

Glympse Bio Raises $22m Series A Financing

FinSMEs
+1